Latest news
Loading news…
Quince Therapeutics
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 High growthGrowth score — momentum trend across web traffic, headcount and other growth signals. South San Francisco, California, United States Founded 2012 11-50 employees For Profit
Quince Therapeutics is developing treatments for Alzheimer's and other degenerative disorders.
Quince Therapeutics on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.
Quince Therapeutics was acquired by Ayma Therapeutics, Inc. in 2026 for $450K.
Total Funding
$161M
Funding Rounds
5
Last Funding
Acquisitions
3
Monthly Visits
Contacts
39
Ticker
QNCX
NASDAQ
Patents
8
1 trademarks
About Quince Therapeutics
Funding & Financials
- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Public
- Ticker
- QNCX
- Exchange
- NASDAQ
- IPO date
- May 8, 2019
- Raised at IPO
- $75M
- Valuation at IPO
- $442M
Web Traffic
- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 13
- Patents granted
- 8
- Trademarks
- 1
- Top patent class
- Organic Chemistry
- IT spend
- $694.88K
Company Info
- Founded
- 2012
- Employees
- 11-50
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 4
- News articles
- 166
- HQ
- South San Francisco, California, United States
- Region
- San Francisco Bay Area, West Coast, Western US
- Diversity spotlight
- Women Founded; Women Led
- Exit date
- May 8, 2019
Signals & Scores
- Heat score
- High
- Growth score
- High
- Trend (7d)
- -1.3
- Trend (30d)
- -3
- Trend (90d)
- 5.5
- Last leadership hire
- Jun 30, 2026
- Last layoff mention
- Jan 26, 2022
Quince Therapeutics Funding Rounds
5 results
Upgrade to Pro to view this datasetUpgrade
| Organization Name | Funding Type | Lead Investor Names | Investor Names | Funding Stage | Org Industries | Org Hq City | Org Hq Country | Org Description | Org Number Of Employees | Org Website | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1–5 of 5Show
Page 1 / 1
Quince Therapeutics Acquisitions
3 results
| Acquiree Name | Acquirer Name | Acquisition Type | Acquisition Terms | Acquiree Industries | Acquiree Hq City | Acquiree Hq Country | Acquiree Description | Acquiree Number Of Employees | Acquirer Industries | Acquirer Hq Country | Acquirer Number Of Employees | Acquirer Ipo Status | Acquiree Website | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OrphAI Therapeutics | — | 2026-05-18 | Quince Therapeutics | Merger | Stock | Artificial Intelligence (AI)BiotechnologyGeneticsMedicalTherapeutics | Guilford | United States | OrphAI Therapeutics formerly known as AI Therapeutics develo… | 2013-01-01 | 1-10 | BiotechnologyHealth CareMedicalPharmaceuticalTherapeutics | United States | 11-50 | Public | 3 | www.ai-therapeutics.com/ | |
| Erydel | — | 2023-07-24 | Quince Therapeutics | Acquisition | Cash & Stock | BiotechnologyHealth CarePharmaceutical | San Giovanni | Italy | Erydel develops technology for drug delivery of pharmacologi… | 2007-02-01 | 11-50 | BiotechnologyHealth CareMedicalPharmaceuticalTherapeutics | United States | 11-50 | Public | 3 | www.erydel.com | |
| Novosteo | — | 2022-05-10 | Quince Therapeutics | Acquisition | — | BiotechnologyHealth CarePharmaceutical | Indiana | United States | Novosteo, test the efficacy of a new drug to help reduce com… | 2017-01-01 | 1-10 | BiotechnologyHealth CareMedicalPharmaceuticalTherapeutics | United States | 11-50 | Public | 3 | www.novosteo.com/ |
1–3 of 3Show
Page 1 / 1
Quince Therapeutics Key People
CFO
Chief Executive Officer
Chief Medical Officer
Chief Corporate Affairs Officer
Executive Medical Director
Chief Scientific Officer
Chief Legal and Administrative Officer and Corporate Secretary
President
39
professional contacts at Quince Therapeutics
Contact execs at Quince Therapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Bulk Dataset Export
Need the data in bulk? Buy the entire dataset.
5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools
Delivered as CSV, JSON or Parquet — at startup-friendly pricing.
Recent News related to Quince Therapeutics
Loading news…
FAQs about Quince Therapeutics
People who checked this page also checked these
Sectors Quince Therapeutics invests & acquires in
Browse the full Acquirezy directory.